Welcome to Sayona Lifescience

Research & Development

SAYONA views Research and Development as a vital component of business strategy that will provide a long-term competitive advantage. The focus on R&D as a key value driver has further strengthened the overall business and growth horizon of the company. SAYONA aims to become a partner of choice to select global pharma companies in terms of New Chemical Entity (NCE) development, Novel Drug Delivery Systems (NDDS) development, custom synthesis and R&D services. Our R&D facility  houses a range of state-of -the-art equipment for formulation development, working on different dosage forms ranging from topical creams, ophthalmological preparations, nasal sprays and dry powder inhalers to name a few. We have an equally well equipped API lab at Advent to synthesize high value APIs for some of our key products.

Our R&D hub is fully equipped with modern amenities and technology for accessing reference material, environmental monitoring, data collection & analysis, record keeping and archiving. A separate Regulatory Affairs team works closely with R&D, Manufacturing and Quality Assurance teams to compile dossiers for submission to various Ministries of Health and / or respective FDAs. Our team is provided with a conducive environment to nurture excellence and innovation that is most essential to develop complex and challenging first-time combination products and also first-to-launch generic products in our focus therapeutic segments. The R&D team is completely involved in any project from concept to Phase IV study tracking market acceptability and after-launch status.

SAYONA's research team is continuously engaged in new research projects to aid process and technology development, development of new molecules, chemical process enhancement and development of innovative drug delivery systems.

SAYONA’s R&D is equipped with sophisticated equipment such as NMR, GC/Mass and HPLCs and the research groups work in a scientific environment matching global standards. Several innovative processes have been developed and global patents have been filed, some of which have already been granted. The R&D is also backed by a full spectrum of library and information management service.

Given the impressive infrastructure comprising in silico drug design, medicinal chemistry, in vitro as well as in vivo microbiology and pharmacology and animal toxicology, SAYONA has emerged as a full-fledged drug discovery centre with end-to-end connectivity from discovery to validation, including pre-clinical evaluation. Orchid is thus ideally poised to be a partner of choice for global discovery outsourcing in the future.

We have R&D team of qualified scientists with background in pharmaceutical sciences and allied areas, networks with the global scientific community including companies, universities and scientists with similar interest areas.

Welcome to Sayona Life Science